Immunotherapy biomarkers in hepatocellular carcinoma: new clues to predicting response
Selecting which patients with hepatocellular carcinoma (HCC) are most likely to benefit from immunotherapy remains…
Author Rachael Babin
Rachael Babin
Rachael Babin is a medical writer, communications expert, digital content producer and trained media host. Rachael co-founded The Oncology Network in 2014. She is Editor-in-Chief of Oncology News Australia, Publisher of The Oncology Newsletter and Host and Creator of The Oncology Podcast. Before creating The Oncology Network, Rachael worked for MOGA, COSA and an international academic publishing house.
ASCO GI 2026: Key gastrointestinal cancer trials shaping practice across CRC, upper GI and hepatobiliary disease
New data presented at the 2026 ASCO Gastrointestinal Cancers Symposium (ASCO GI) highlight continued momentum…
Neoadjuvant chemoradiotherapy and surgery show similar long-term survival to surgery with adjuvant therapy in oesophageal squamous cell carcinoma
New data from a phase 3 randomised clinical trial published in JAMA Network Open has…
Balancing hope and evidence: ethical tensions in “right to try” access in oncology
In a recent Viewpoint in JAMA Oncology, a group of oncology ethicists and clinicians examine…
Long-term reductions in alcohol consumption linked to lower cancer mortality in Australia
A new study in the British Journal of Cancer has used nearly seven decades of…
Hormonal contraceptive use and breast cancer risk
A recent cohort study of more than 2 million adolescent girls and women has provided…
NATALEE 4-year data: Ribociclib extends recurrence-free survival in early breast cancer
Hormone receptor (HR)–positive, ERBB2 (formerly HER2)–negative breast cancer is the most common subtype, accounting for…
Patient-reported outcomes provide independent prognostic information in cancer
A new systematic review and meta-analysis published in JAMA Oncology suggests that patient-reported outcomes (PROs)…
Adjuvant chemoradiation plus immunotherapy improves survival in extrahepatic biliary cancers
A new multicentre trial has found that combining chemoradiation with immunotherapy significantly improves survival in…
Immunotherapy duo shows promise in Australian rare ovarian and endometrial clear cell cancers study
A phase 2 Australian-New Zealand study has reported encouraging results for the combination of nivolumab…